Department of Anesthesiology and Pain Medicine, Eulji University Uijeongbu Eulji Medical Center, Eulji Uni-Versity School of Medicine, Uijeongbu, 11759, Republic of Korea.
Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, 164, World Cup-Ro, Yeongtong-Gu, Suwon, 16499, Republic of Korea.
Sci Rep. 2024 Jul 18;14(1):16599. doi: 10.1038/s41598-024-62495-0.
Optimal fluid management during major surgery is of considerable concern to anesthesiologists. Although crystalloids are the first choice for fluid management, the administration of large volumes of crystalloids is associated with poor postoperative outcomes. Albumin can be used for fluid management and may protect renal function. However, data regarding the effects of albumin administration on kidney function are conflicting. As such, the present study aimed to investigate the effect of albumin administration on renal function in patients undergoing major surgery and compare its effects with those of crystalloid fluid. The Embase, Medline, Web of Science, Cochrane Library, and KoreaMed databases were searched for relevant studies. The primary endpoint of the meta-analysis was the incidence of postoperative kidney injury, including acute kidney injury and renal replacement therapy. Twelve studies comprising 2311 patients were included; the primary endpoint was analyzed in four studies comprising 1749 patients. Perioperative albumin levels in patients undergoing major surgery did not significantly influence kidney dysfunction (p = 0.98). Postoperative fluid balance was less positive in patients who underwent major surgery and received albumin than in those who received crystalloids. Owing to the limitations of this meta-analysis, it remains unclear whether albumin administration during major surgery is better than crystalloid fluid for improving postoperative renal function.
在大型手术中,进行最佳的液体管理是麻醉师非常关注的问题。虽然晶体液是液体管理的首选,但大量输注晶体液与术后不良结局有关。白蛋白可用于液体管理,并且可能保护肾功能。然而,关于白蛋白给药对肾功能影响的数据存在矛盾。因此,本研究旨在探讨白蛋白给药对行大型手术患者肾功能的影响,并将其与晶体液的影响进行比较。检索了 Embase、Medline、Web of Science、Cochrane Library 和 KoreaMed 数据库中相关的研究。荟萃分析的主要终点是术后肾脏损伤的发生率,包括急性肾损伤和肾脏替代治疗。共纳入了 12 项研究,包含 2311 名患者;对其中 4 项研究,包含 1749 名患者的主要终点进行了分析。大型手术患者围手术期白蛋白水平并不显著影响肾功能障碍(p=0.98)。接受白蛋白的大型手术患者与接受晶体液的患者相比,术后液体平衡更为负面。由于本荟萃分析的局限性,白蛋白给药在改善术后肾功能方面是否优于晶体液仍不清楚。